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Recognized melioidosis-endemic areas are widening.
In the South Pacific, melioidosis is endemic in New
Caledonia, northern Australia, and Papua New Guinea. We
report the first 4 documented cases of human melioidosis
from New Caledonia. Molecular typing of 2 Burkholderia
pseudomallei isolates suggests a link to Australian strains.
M
elioidosis, a tropical disease endemic in areas of
Southeast Asia and northern Australia (1), is caused
by Burkholderia pseudomallei, an environmental bacteri-
um that lives in soil and surface water (2). This disease is
increasingly recognized as an emerging problem because it
is more often recognized and identified. Recent new “hot
spots” have been reported in Mauritius (3), the Indian sub-
continent (4), the Americas (5,6), and the Caribbean (7). In
the South Pacific, melioidosis is a rare (8), but likely
underdiagnosed, illness.
New Caledonia is located in Oceania, ≈2,000 km north-
east of Sydney, Australia. With nearly 220,000 inhabitants,
the country is a discrete epidemiologic entity with Pacific
Island characteristics and a multicultural (mainly
Melanesian, European, and Polynesian) population. The
country has 2 provinces on the main island and a third
province of smaller islands. Total land area is 18,575 km2,
slightly smaller than New Jersey. In New Caledonia, 4
cases of melioidosis have been diagnosed in the last 6
years. All were in Melanesians living in the Northern
Province, none of whom had traveled abroad, which sug-
gests this area is another discrete focus of endemic melioi-
dosis. The average age of patients was 53 years; 3 had
recognized risk factors for melioidosis, and all 4 were
heavy kava drinkers.
The Cases
Melioidosis was confirmed for the first time in New
Caledonia in February 1999 in a 46-year-old male nurse
who worked at the health center of Ouegoa, a village in the
Northern Province. He was admitted to the hospital with
fever, acute renal insufficiency, pneumonia, and septic
shock. Blood culture grew an oxidase-positive, gram-
negative rod, which was initially identified as a
Pseudomonas sp. by the local laboratory but later con-
firmed as B. pseudomallei by the Pasteur Institute when
the patient was transferred to the hospital in the capital
city, Nouméa. He had been treated for tuberculosis 20
years earlier. He required intubation and ventilation, and
treatment was begun with a combination of ceftazidime
and amikacin. Ten days after admission, when B. pseudo-
mallei infection was confirmed, treatment was changed to
the combination of imipenem and trimethoprim/sul-
famethoxazole. Numerous cutaneous abscesses cultured B.
pseudomallei, and he slowly recovered.
The second case came from the same location of
Ouegoa but not from the same tribe. The patient was a 43-
year-old man with diabetes mellitus and chronic renal fail-
ure who required a kidney transplant in 2001. He was
taking the immunosuppressant medication tacrolimus
when “B. gladioli” septicemia was diagnosed in April
2002. Two months later, he was admitted to the hospital
with pneumonia, and blood cultures grew B. pseudomallei.
He made a full recovery after therapy with a combination
of ceftazidime and trimethoprim/sulfamethoxazole.
In July 2003, a 58-year-old man, living in Poum, ≈50
km from Ouegoa, was admitted with fever, pneumonia,
and renal impairment. This man had tuberculosis in 1993
and was a smoker and alcoholic. Treatment was with
amoxicillin/clavulanate for 24 hours followed by a combi-
nation of cefotaxime, ofloxacin, and metronidazole for 48
hours. He was transferred to Nouméa with severe hypox-
emia from bilateral pneumonia and hepatocellular insuffi-
ciency. A gram-negative bacillus was isolated from
bronchial secretions. Therapy was changed to a combina-
tion of ceftazidime and ciprofloxacin, and he slowly
improved. The organism was identified as B. pseudomallei
7 days after the patient’s transfer to Nouméa. Alung lobec-
tomy was performed after 2 months for persisting pul-
monary infection, and B. pseudomallei was cultured from
the surgical specimen. The patient continued to receive
trimethoprim/sulfamethoxazole on a long-term basis.
In June 2004, a 67-year-old woman with a history of
diabetes mellitus came to the hospital with abscesses on
her thigh, from which B. pseudomallei was cultured. She
was otherwise healthy and recovered fully after receiving
therapy for melioidosis. She lives in Poindimie, about 200
km southeast of Ouegoa.
The bacterium, also called Whitmore bacillus, is an oxi-
dase-positive, gram-negative rod. It is commonly misiden-
tified, sometimes as various species of the Pseudomonas
genus. The bacterium grows aerobically on most agar
media and usually produces clearly visible colonies within
24 hours at 37°C. In our cases, B. pseudomallei was iden-
tified with API 20NE and API 32GN (API system SA,
Lyon, France). Two of the isolates were sent to the Centre
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Institute in Paris, where the identity was confirmed by
amplifying and sequencing the 16S rRNA gene. These
strains were also defined by multilocus sequence typing
(MLST) at Imperial College, London, and compared with
isolates from Australia and Thailand. Both strains were
new sequence types. When a minimum evolution analysis
was performed on the concatenated sequences of the 2
strains and compared with Australian and Thai strains on
the MLST website (http://bpseudomallei.mlst.net/), the
New Caledonian strains clustered well within groups of
Australian sequence types (Figure). Furthermore, 1 of the
strains was a single-locus variant (i.e., 6 of 7 alleles iden-
tical) of a strain from the east coast of Australia. This com-
parison suggests that New Caledonian B. pseudomallei
strains are linked to Australian strains (9). New Caledonia
is a fragment of the ancient continent of Gondwana and
subsequently separated from Australia and New Zealand.
The diverse but distinct phylogeny of strains of B. pseudo-
mallei in Southeast Asia and Australia may reflect geo-
graphic isolation over long periods.
Conclusions
In these cases, a lack of facilities for identifying the bac-
terium, especially in countries where incidence is unknown,
resulted in delays before diagnosis and definitive treatment.
The classic resistance to colistin and gentamicin but sensi-
tivity to amoxicillin/clavulanate seen in oxidase-positive,
gram-negative rods may facilitate diagnosis.
In New Caledonia, the 4 patients had a variety of symp-
toms, from pneumonia, with or without septic shock, to
cutaneous abscesses. The last case shows that exposure to
B. pseudomallei does not always result in severe disease.
The severity of illness probably depends on a balance
between the bacterial strain’s virulence, size of the infec-
tious dose, delay before diagnosis, and immune status of
the host (2). Risk factors for the patients were similar to
those described elsewhere (2,8) and included diabetes,
alcohol excess, chronic renal disease, and immunosup-
pression. Interestingly, all patients were heavy drinkers of
kava, an extract of the plant Piper methysticum, which is
drunk as an alternative to alcohol. Kava may be associat-
ed with melioidosis in some aboriginal communities in
northern Australia (10). In New Caledonia, as in Australia,
this “traditional” consumption is recent. Kava first
appeared in New Caledonia ≈15 years ago as an import of
Melanesian tradition mainly from Vanuatu. The roots are
dried then pounded into powder and exported to New
Caledonia and Australia where it is mixed with water to
produce a brownish brew consumed for its psychoactive
properties. Whether the association of melioidosis with
kava consumption is an independent risk and whether it is
because of possible ingestion of contaminated brew (11)
or because of increased susceptibility of kava drinkers to
melioidosis after exposure to B. pseudomallei requires
further evaluation.
Melioidosis mainly affects persons who have direct
contact with wet soil and have an underlying predisposi-
tion to infection. In the bush, many Melanesian persons
spend a great deal of time outdoors with bare feet or wear-
ing sandals, which increases percutaneous exposure to soil
or muddy water during the wet season. New Caledonia
often has periodic and heavy rain throughout the year. Four
cases in 6 years represent an average annual incidence of
1.81/100,000 in the Northern Province, with 22.4/100,000
in the Ouegoa area, which suggests a high-prevalence
focal region of melioidosis.
In conclusion, melioidosis cases have emerged in
Melanesian persons, including those with diabetes, in a
high-rainfall area in New Caledonia. Sampling of soil and
ground water (and kava) for B. pseudomallei could be per-
formed in this region to clarify the distribution of the bac-
terium and increase our understanding of this public health
concern.
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Figure. Phylogenetic tree constructed from the concatenated
sequences of the 7 multilocus sequence type loci from
Burkholderia pseudomallei isolates, illustrating the relationship of
the 2 Caledonian strains to Australian and Thai isolates.Dr Le Hello is a medical biologist at the Institut Pasteur of
New Caledonia. His research interests are the molecular epidemi-
ology of bacteria in the South Pacific.
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